Publication:
Regulatory considerations for developing remote measurement technologies for Alzheimer's disease research.

Simple item page
cris.virtual.author-orcid0000-0003-0295-6834
cris.virtualsource.author-orcid7510c4e7-bf62-4cfb-9b49-ecb826f2f45d
datacite.rightsopen.access
dc.contributor.authorErdemli, Gül
dc.contributor.authorGrammatikopoulou, Margarita
dc.contributor.authorWagner, Bertil
dc.contributor.authorVairavan, Srinivasan
dc.contributor.authorCurcic, Jelena
dc.contributor.authorAarsland, Dag
dc.contributor.authorWittenberg, Gayle
dc.contributor.authorNikolopoulos, Spiros
dc.contributor.authorMuurling, Marijn
dc.contributor.authorFroehlich, Holger
dc.contributor.authorde Boer, Casper
dc.contributor.authorShanbhag, Niraj M
dc.contributor.authorNies, Vera J M
dc.contributor.authorCoello, Neva
dc.contributor.authorGove, Dianne
dc.contributor.authorDiaz, Ana
dc.contributor.authorFoy, Suzanne
dc.contributor.authorDartee, Wim
dc.contributor.authorBrem, Anna- Katharine
dc.date.accessioned2024-10-21T11:39:07Z
dc.date.available2024-10-21T11:39:07Z
dc.date.issued2024-09-04
dc.description.abstractThe Remote Assessment of Disease and Relapse – Alzheimer’s Disease (RADAR-AD) consortium evaluated remote measurement technologies (RMTs) for assessing functional status in AD. The consortium engaged with the European Medicines Agency (EMA) to obtain feedback on identification of meaningful functional domains, selection of RMTs and clinical study design to assess the feasibility of using RMTs in AD clinical studies. We summarized the feedback and the lessons learned to guide future projects.
dc.description.sponsorshipUniversity Hospital of Geriatric Psychiatry and Psychotherapy
dc.identifier.doi10.48620/36403
dc.identifier.pmid39232033
dc.identifier.publisherDOI10.1038/s41746-024-01211-8
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/47918
dc.language.isoen
dc.publisherNature Research
dc.relation.ispartofnpj Digital Medicine
dc.relation.issn2398-6352
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleRegulatory considerations for developing remote measurement technologies for Alzheimer's disease research.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.issue1
oaire.citation.volume7
oairecerif.author.affiliationUniversity Hospital of Geriatric Psychiatry and Psychotherapy
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.description.ispublishedpub
unibe.refereetrue
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
s41746-024-01211-8.pdf
Size:
710.61 KB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by-nc-nd/4.0
Content:
published
Download

Collections

Publications